We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Veeco
VECO
$3.11B
| $322K | ﹤0.01% |
+15,232
| New | +$313K |
|
|
GTM
1352
ZoomInfo Technologies
GTM
$1.05B
| $319K | ﹤0.01% |
12,923
-1,190
| -8% | -$30.5K |
|
1353
CALL
iShares China Large-Cap ETF
FXI
$4.35B
| $319K | ﹤0.01% |
10,800
-142,200
| -93% | -$4.27M |
|
|
1354
PUT
iShares China Large-Cap ETF
FXI
$4.35B
| $319K | ﹤0.01% |
10,800
-81,200
| -88% | -$2.44M |
|
|
CTLT
1355
DELISTED
CATALENT, INC.
CTLT
| $318K | ﹤0.01% |
+4,847
| New | +$299K |
|
1356
Hilltop Holdings
HTH
$2.28B
| $318K | ﹤0.01% |
+10,722
| New | +$338K |
|
1357
CALL
Lam Research
LRCX
$369B
| $318K | ﹤0.01% |
6,000
-1,000
| -14% | -$49.1K |
|
1358
Clear Channel Outdoor Holdings
CCO
$1.23B
| $318K | ﹤0.01% |
265,000
| – | – |
|
|
RCM
1359
DELISTED
R1 RCM Inc. Common Stock
RCM
| $318K | ﹤0.01% |
+21,197
| New | +$290K |
|
1360
Yext
YEXT
$569M
| $318K | ﹤0.01% |
+33,039
| New | +$254K |
|
1361
Azenta
AZTA
$1.38B
| $317K | ﹤0.01% |
+7,107
| New | +$352K |
|
1362
Manulife Financial
MFC
$74B
| $317K | ﹤0.01% |
17,246
+5,667
| +49% | +$108K |
|
|
NVTA
1363
DELISTED
Invitae Corporation
NVTA
| $316K | ﹤0.01% |
+234,173
| New | +$461K |
|
1364
California Resources
CRC
$4.63B
| $316K | ﹤0.01% |
+8,206
| New | +$340K |
|
1365
Compass Minerals
CMP
$1.21B
| $315K | ﹤0.01% |
+9,197
| New | +$368K |
|
|
CHX
1366
DELISTED
ChampionX
CHX
| $315K | ﹤0.01% |
11,620
-1,938
| -14% | -$57.9K |
|
1367
MasterCraft Boat Holdings
MCFT
$582M
| $315K | ﹤0.01% |
+10,353
| New | +$322K |
|
1368
Twilio
TWLO
$29.8B
| $314K | ﹤0.01% |
+4,717
| New | +$291K |
|
1369
CALL
Stryker
SYK
$131B
| $314K | ﹤0.01% |
1,100
| – | – |
|
1370
Cognex
CGNX
$11.2B
| $314K | ﹤0.01% |
6,327
-1,354
| -18% | -$68.5K |
|
1371
Axos Financial
AX
$5.9B
| $313K | ﹤0.01% |
8,489
+2,835
| +50% | +$122K |
|
1372
Haemonetics
HAE
$3.94B
| $313K | ﹤0.01% |
+3,780
| New | +$306K |
|
1373
Smith & Wesson
SWBI
$660M
| $311K | ﹤0.01% |
+25,294
| New | +$271K |
|
1374
ServiceNow
NOW
$118B
| $311K | ﹤0.01% |
3,350
-12,760
| -79% | -$1.11M |
|
1375
Avita Medical
RCEL
$142M
| $311K | ﹤0.01% |
+22,287
| New | +$237K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.